Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
The Neuroradiology Journal|June 12, 2023
Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneityCymon N Kersch, Leslie L Muldoon, Cheryl J Claunch, et al.Journal of Magnetic Resonance Imaging : JMRI|January 10, 2018
Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of careCsanad G Varallyay, Eric Nesbit, Andrea Horvath, et al.Radiology|December 4, 2012
Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survivalSeymur Gahramanov, Leslie L Muldoon, Csanad G Varallyay, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 15, 2013
High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticleCsanad G Varallyay, Eric Nesbit, Rongwei Fu, et al.Journal of Vascular and Interventional Radiology : JVIR|February 26, 2008
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trialsDavid A Stenstrom, Leslie L Muldoon, Hector Armijo-Medina, et al.International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot studySeymur Gahramanov, Ahmed M Raslan, Leslie L Muldoon, et al.Neuro-Oncology Advances|December 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypesJared Stoller, Cymon N Kersch, Leslie L Muldoon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Chemotherapy delivery issues in central nervous system malignancy: a reality checkLeslie L Muldoon, Carole Soussain, Kristoph Jahnke, et al.Neuro-Oncology|December 18, 2010
Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytolEdit Dósa, Daniel J Guillaume, Marianne Haluska, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|August 3, 2010
Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determinationXin Li, William D Rooney, Csanád G Várallyay, et al.Pageof 7